Tygh Capital Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-51,600
Closed -$3.48M 86
2020
Q1
$3.48M Buy
51,600
+20,753
+67% +$1.4M 0.78% 54
2019
Q4
$2.6M Buy
+30,847
New +$2.6M 0.43% 72
2019
Q1
Sell
-127,973
Closed -$4.29M 85
2018
Q4
$4.29M Sell
127,973
-86,458
-40% -$2.89M 0.9% 50
2018
Q3
$11.2M Sell
214,431
-36,338
-14% -$1.9M 1.84% 12
2018
Q2
$7.85M Buy
+250,769
New +$7.85M 1.33% 29